Resources

This document guides aged care providers on how to provide Monthly Care Statements to their residents.

This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 22 July to 4 August 2024.

These are the presentation slides for the Introduction to General Practice in Aged Care Incentive webinar held on 6 August 2024.

This form is for individuals entering the Private Hospital Stream (PHS) 2024 Expression of Interest (EOI) internship.

This publication includes historical data about pharmacy programs funded under previous Community Pharmacy Agreements (CPAs).

This publication includes historical data about rural support and Aboriginal and Torres Strait Islander pharmacy programs data funded under previous Community Pharmacy Agreements (CPAs).

Learn more about MyMedicare eligibility, registration, and benefits.

These FAQs provide more information to applicants applying for Postgraduate Year (PGY) 1 funded places under the 2024 PHS EOI recruitment process.

This communique is published following each meeting of the MBS Review Advisory Committee (MRAC). It summarises the meeting outcomes, progress on current reviews and advice about upcoming reviews.

This guidance from the Environmental Health Standing Committee (enHealth) provides nationally consistent approaches to health protection measures when smoke impacts from landscape fires last for a prolonged period (more than 2 to 3 days).

This document provides guidance to public agencies for health advice during fluctuations in air pollution from fine particulate matter (PM2.5) and for forecast 24-hour PM2.5 concentrations.

An update from the Better Renal Services Steering Committee after their meeting on 15 July 2024.

This infographic shows the number of flu (influenza) vaccinations reported to the Australian Immunisation Register (AIR) during 2021–2024, since 1 March.

This report presents several methods currently used in Australia to detect and reduce nitrous oxide leaks in healthcare facilities. It is intended for use by clinicians and healthcare facility managers to assist leak detection and inform choices about the methodology best suited for their context.

This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. It provides further clarity on future access arrangements via the PBS.

This fact sheet provides a table of frequently claimed items based on 1 July 2024 Medical Benefit Schedule (MBS).